Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study (Q56003767)
Jump to navigation
Jump to search
scientific article published on 01 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study |
scientific article published on 01 December 2006 |
Statements
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study (English)
W Sulowicz
A L M de Francisco
M Klinger
V Vargemezis
F Metivier
F C Dougherty
D Oguey
BA16260 Study Invesigators
1 December 2006